DAR ES SALAAM — [Malaria Consortium] Malaria remains a major public health issue in South Sudan, with the disease accounting for over 38 percent of outpatient visits and around 64 percent of inpatient deaths in 2025. As antimalarial drug resistance continues to emerge across East Africa, there is a growing concern that the malaria burden could increase if resistance spreads further and undermines the effectiveness of existing prevention and treatment drugs, including artemisinin-based combination therapies (ACTs).
"We aggregate wires to encourage regional discovery, sending readers directly back to the original source to explore full coverage."
This is a normalized overview of the breaking feed event. The complete, official release detailing all points, background context, and statements remains hosted by the original publisher.